GenomeNet

Database: UniProt/SWISS-PROT
Entry: ACSA_MOUSE
LinkDB: ACSA_MOUSE
Original site: ACSA_MOUSE 
ID   ACSA_MOUSE              Reviewed;         701 AA.
AC   Q9QXG4; Q8BK97;
DT   03-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   27-MAR-2024, entry version 157.
DE   RecName: Full=Acetyl-coenzyme A synthetase, cytoplasmic;
DE            EC=6.2.1.1 {ECO:0000269|PubMed:11150295, ECO:0000269|PubMed:16790548, ECO:0000269|PubMed:28562591};
DE   AltName: Full=Acetate--CoA ligase;
DE   AltName: Full=Acetyl-CoA synthetase;
DE            Short=ACS;
DE            Short=AceCS;
DE   AltName: Full=Acetyl-CoA synthetase 1 {ECO:0000303|PubMed:11150295, ECO:0000303|PubMed:16790548};
DE            Short=AceCS1 {ECO:0000303|PubMed:11150295, ECO:0000303|PubMed:16790548};
DE   AltName: Full=Acyl-CoA synthetase short-chain family member 2;
DE   AltName: Full=Acyl-activating enzyme;
DE   AltName: Full=Propionate--CoA ligase;
DE            EC=6.2.1.17 {ECO:0000269|PubMed:11150295};
GN   Name=Acss2; Synonyms=Acas2, Acecs1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12049778; DOI=10.1016/s0925-4773(02)00097-7;
RA   Loikkanen I., Haghighi S., Vainio S., Pajunen A.;
RT   "Expression of cytosolic acetyl-CoA synthetase gene is developmentally
RT   regulated.";
RL   Mech. Dev. 115:139-141(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Eye;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N-3; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=11150295; DOI=10.1074/jbc.m008782200;
RA   Fujino T., Kondo J., Ishikawa M., Morikawa K., Yamamoto T.T.;
RT   "Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the
RT   oxidation of acetate.";
RL   J. Biol. Chem. 276:11420-11426(2001).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, ACETYLATION AT LYS-661,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16790548; DOI=10.1073/pnas.0604392103;
RA   Hallows W.C., Lee S., Denu J.M.;
RT   "Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10230-10235(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain cortex;
RX   PubMed=17114649; DOI=10.1074/mcp.m600046-mcp200;
RA   Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,
RA   Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B.,
RA   Panse C., Schlapbach R., Mansuy I.M.;
RT   "Qualitative and quantitative analyses of protein phosphorylation in naive
RT   and stimulated mouse synaptosomal preparations.";
RL   Mol. Cell. Proteomics 6:283-293(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 AND SER-267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion affinity
RT   chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-263; SER-265 AND
RP   SER-267, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=28552616; DOI=10.1016/j.molcel.2017.04.026;
RA   Li X., Yu W., Qian X., Xia Y., Zheng Y., Lee J.H., Li W., Lyu J., Rao G.,
RA   Zhang X., Qian C.N., Rozen S.G., Jiang T., Lu Z.;
RT   "Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal
RT   Biogenesis and Autophagy.";
RL   Mol. Cell 66:684-697(2017).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DISRUPTION PHENOTYPE, AND INTERACTION WITH CREBBP.
RX   PubMed=28562591; DOI=10.1038/nature22405;
RA   Mews P., Donahue G., Drake A.M., Luczak V., Abel T., Berger S.L.;
RT   "Acetyl-CoA synthetase regulates histone acetylation and hippocampal
RT   memory.";
RL   Nature 546:381-386(2017).
CC   -!- FUNCTION: Catalyzes the synthesis of acetyl-CoA from short-chain fatty
CC       acids (PubMed:11150295, PubMed:16790548, PubMed:28562591). Acetate is
CC       the preferred substrate but can also utilize propionate with a much
CC       lower affinity (PubMed:11150295). Nuclear ACSS2 promotes glucose
CC       deprivation-induced lysosomal biogenesis and autophagy, tumor cell
CC       survival and brain tumorigenesis (By similarity). Glucose deprivation
CC       results in AMPK-mediated phosphorylation of ACSS2 leading to its
CC       translocation to the nucleus where it binds to TFEB and locally
CC       produces acetyl-CoA for histone acetylation in the promoter regions of
CC       TFEB target genes thereby activating their transcription (By
CC       similarity). The regulation of genes associated with autophagy and
CC       lysosomal activity through ACSS2 is important for brain tumorigenesis
CC       and tumor survival (By similarity). Acts as a chromatin-bound
CC       transcriptional coactivator that up-regulates histone acetylation and
CC       expression of neuronal genes (PubMed:28562591). Can be recruited to the
CC       loci of memory-related neuronal genes to maintain a local acetyl-CoA
CC       pool, providing the substrate for histone acetylation and promoting the
CC       expression of specific genes, which is essential for maintaining long-
CC       term spatial memory (PubMed:28562591). {ECO:0000250|UniProtKB:Q9NR19,
CC       ECO:0000269|PubMed:11150295, ECO:0000269|PubMed:16790548,
CC       ECO:0000269|PubMed:28562591}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetate + ATP + CoA = acetyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:23176, ChEBI:CHEBI:30089, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:456215; EC=6.2.1.1;
CC         Evidence={ECO:0000269|PubMed:11150295, ECO:0000269|PubMed:16790548,
CC         ECO:0000269|PubMed:28562591};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23177;
CC         Evidence={ECO:0000305|PubMed:11150295, ECO:0000305|PubMed:16790548};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + CoA + propanoate = AMP + diphosphate + propanoyl-CoA;
CC         Xref=Rhea:RHEA:20373, ChEBI:CHEBI:17272, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392,
CC         ChEBI:CHEBI:456215; EC=6.2.1.17;
CC         Evidence={ECO:0000269|PubMed:11150295};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20374;
CC         Evidence={ECO:0000305|PubMed:11150295};
CC   -!- ACTIVITY REGULATION: Inhibited by acetylation at Lys-661 and activated
CC       by deacetylation mediated by the deacetylases SIRT1 and SIRT3.
CC       {ECO:0000269|PubMed:16790548}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.11 mM for acetate {ECO:0000269|PubMed:11150295};
CC         KM=3.4 mM for propionate {ECO:0000269|PubMed:11150295};
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with TFEB (By similarity).
CC       AMPK-mediated phosphorylated form at Ser-659 interacts with KPNA1; this
CC       interaction results in nuclear translocation of ACSS2 (By similarity).
CC       Interacts with the 'Thr-172' phosphorylated form of PRKAA2 (By
CC       similarity). Interacts with CREBBP (PubMed:28562591).
CC       {ECO:0000250|UniProtKB:Q9NR19, ECO:0000269|PubMed:28562591}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:11150295,
CC       ECO:0000269|PubMed:28552616}. Cytoplasm {ECO:0000269|PubMed:28562591}.
CC       Nucleus {ECO:0000269|PubMed:28552616, ECO:0000269|PubMed:28562591}.
CC       Note=Glucose deprivation results in its AMPK-dependent phosphorylation
CC       and subsequent nuclear translocation. Phosphorylation at Ser-659, leads
CC       to exposure of its nuclear localization signal which is required for
CC       its interaction with KPNA1 and subsequent translocation to the nucleus
CC       (By similarity). Found in the cytoplasm in undifferentiated neurons and
CC       upon differentiation, translocates to nucleus (PubMed:28562591).
CC       {ECO:0000250|UniProtKB:Q9NR19, ECO:0000269|PubMed:28562591}.
CC   -!- TISSUE SPECIFICITY: Expressed in the hippocampus.
CC       {ECO:0000269|PubMed:28562591}.
CC   -!- PTM: Reversibly acetylated at Lys-661 (PubMed:16790548). The acetyl-CoA
CC       synthase activity is inhibited by acetylation and activated by
CC       deacetylation mediated by the deacetylases SIRT1 and SIRT3.
CC       {ECO:0000269|PubMed:16790548}.
CC   -!- DISRUPTION PHENOTYPE: Knockdown in the hippocampus decreases histone
CC       acetylation and is accompanied by impaired object location memory and
CC       defective up-regulation of immediate early genes following training.
CC       {ECO:0000269|PubMed:28562591}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF216873; AAF24510.1; -; mRNA.
DR   EMBL; AK053877; BAC35571.1; -; mRNA.
DR   EMBL; AL844852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC051432; AAH51432.1; -; mRNA.
DR   CCDS; CCDS16950.1; -.
DR   RefSeq; NP_062785.2; NM_019811.3.
DR   AlphaFoldDB; Q9QXG4; -.
DR   SMR; Q9QXG4; -.
DR   BioGRID; 208597; 2.
DR   DIP; DIP-61210N; -.
DR   IntAct; Q9QXG4; 3.
DR   STRING; 10090.ENSMUSP00000029135; -.
DR   ChEMBL; CHEMBL2924; -.
DR   iPTMnet; Q9QXG4; -.
DR   PhosphoSitePlus; Q9QXG4; -.
DR   SwissPalm; Q9QXG4; -.
DR   EPD; Q9QXG4; -.
DR   jPOST; Q9QXG4; -.
DR   MaxQB; Q9QXG4; -.
DR   PaxDb; 10090-ENSMUSP00000029135; -.
DR   ProteomicsDB; 285543; -.
DR   Pumba; Q9QXG4; -.
DR   Antibodypedia; 1332; 515 antibodies from 33 providers.
DR   DNASU; 60525; -.
DR   Ensembl; ENSMUST00000029135.15; ENSMUSP00000029135.9; ENSMUSG00000027605.19.
DR   GeneID; 60525; -.
DR   KEGG; mmu:60525; -.
DR   UCSC; uc008nku.1; mouse.
DR   AGR; MGI:1890410; -.
DR   CTD; 55902; -.
DR   MGI; MGI:1890410; Acss2.
DR   VEuPathDB; HostDB:ENSMUSG00000027605; -.
DR   eggNOG; KOG1175; Eukaryota.
DR   GeneTree; ENSGT00940000156358; -.
DR   HOGENOM; CLU_000022_3_6_1; -.
DR   InParanoid; Q9QXG4; -.
DR   OMA; INVSYNC; -.
DR   OrthoDB; 144557at2759; -.
DR   TreeFam; TF300417; -.
DR   Reactome; R-MMU-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-MMU-71384; Ethanol oxidation.
DR   BioGRID-ORCS; 60525; 2 hits in 79 CRISPR screens.
DR   ChiTaRS; Acss2; mouse.
DR   PRO; PR:Q9QXG4; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q9QXG4; Protein.
DR   Bgee; ENSMUSG00000027605; Expressed in aorta tunica adventitia and 252 other cell types or tissues.
DR   ExpressionAtlas; Q9QXG4; baseline and differential.
DR   Genevisible; Q9QXG4; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003987; F:acetate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0050218; F:propionate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IMP:UniProtKB.
DR   GO; GO:0019413; P:acetate biosynthetic process; ISO:MGI.
DR   GO; GO:0006085; P:acetyl-CoA biosynthetic process; IDA:MGI.
DR   GO; GO:0008610; P:lipid biosynthetic process; ISO:MGI.
DR   GO; GO:0007616; P:long-term memory; IMP:UniProtKB.
DR   GO; GO:0035066; P:positive regulation of histone acetylation; IMP:UniProtKB.
DR   GO; GO:0019542; P:propionate biosynthetic process; ISO:MGI.
DR   CDD; cd05966; ACS; 1.
DR   Gene3D; 3.30.300.30; -; 1.
DR   Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1.
DR   InterPro; IPR032387; ACAS_N.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig_com.
DR   InterPro; IPR042099; ANL_N_sf.
DR   PANTHER; PTHR24095; ACETYL-COENZYME A SYNTHETASE; 1.
DR   PANTHER; PTHR24095:SF126; ACETYL-COENZYME A SYNTHETASE, CYTOPLASMIC; 1.
DR   Pfam; PF16177; ACAS_N; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; ATP-binding; Cytoplasm; Ligase; Lipid metabolism;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..701
FT                   /note="Acetyl-coenzyme A synthetase, cytoplasmic"
FT                   /id="PRO_0000208424"
FT   REGION          1..107
FT                   /note="Interaction with TFEB"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NR19"
FT   REGION          1..37
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           656..668
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NR19"
FT   COMPBIAS        1..24
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         219..222
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   BINDING         363
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   BINDING         439..441
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         463..468
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         552
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         567
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         575
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   BINDING         636
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         418
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NR19"
FT   MOD_RES         659
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NR19"
FT   MOD_RES         661
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16790548"
FT   CONFLICT        498..500
FT                   /note="PAI -> LQS (in Ref. 1; AAF24510)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        655..657
FT                   /note="PKT -> LKP (in Ref. 1; AAF24510)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   701 AA;  78862 MW;  D1EA6312CD4527D7 CRC64;
     MGLPEERRKS GSGSRAREET GAEGRVRGWS PPPEVRRSAH VPSLQRYREL HRRSVEEPRE
     FWGNIAKEFY WKTACPGPFL QYNFDVTKGK IFTEWMKGAT TNICYNVLDR NVHEKKLGDK
     VAFYWEGNEP GETTKITYRE LLVQVCQFSN VLRKQGIQKG DRVAIYMPMI LELVVAMLAC
     ARLGALHSIV FAGFSAESLC ERILDSSCCL LITTDAFYRG EKLVNLKELA DESLEKCREK
     GFPVRCCIVV KHLGRAELGM NDSPSQSPPV KRPCPDVQIC WNEGVDLWWH ELMQQAGDEC
     EPEWCDAEDP LFILYTSGST GKPKGVVHTI GGYMLYVATT FKYVFDFHPE DVFWCTADIG
     WITGHSYVTY GPLANGATSV LFEGIPTYPD EGRLWSIVDK YKVTKFYTAP TAIRMLMKFG
     DDPVTKHSRA SLQVLGTVGE PINPEAWLWY HRVVGSQRCP IVDTFWQTET GGHMLTPLPG
     ATPMKPGSAS FPFFGVAPAI LNESGEELEG EAEGYLVFKQ PWPGIMRTVY GNHTRFETTY
     FKKFPGYYVT GDGCRRDQDG YYWITGRIDD MLNVSGHLLS TAEVESALVE HEAVAEAAVV
     GHPHPVKGEC LYCFVTLCDG HTFSPTLTEE LKKQIREKIG PIATPDYIQN APGLPKTRSG
     KIMRRVLRKI AQNDHDLGDT STVADPSVIN HLFSHRCLTT Q
//
DBGET integrated database retrieval system